In The Press January 22, 2020

Goodwin Lawyers Give a Look at Biosimilar Litigation (Not So Different Podcast)

In the past decade of experience with the Biologics Price Competition and Innovation Act, a number of questions about the biosimilar pathway have been resolved through litigation. In this podcast episode, hosts from The Center for Biosimilars speak with lawyers Robert Cerwinski and Alexandra Valenti, both partners in Goodwin’s IP Litigation practice, about experience with litigation, the road ahead for biosimilars, and Goodwin's recently published guide to biosimilar litigation. Listen to the podcast episode here.